Appropriate glycated haemoglobin testing frequency to monitor patients with type 2 diabetes
Glycated haemoglobin (HbA1c) is used to monitor glycaemic control among patients with type 2 diabetes (T2DM). Glycated haemoglobin represents a 3-month glycaemic average, with the most recent 6 weeks of glycaemia having the greatest influence. Analytical and biological variation introduce imprecision into any single Hb...